Editorial Commentary
Online First
The articles on this page have been copyedited and reviewed and approved by the authors. They have not yet been scheduled for a specific issue. For published content, please visit Archive.
Editorial Commentary
Advancing HER2-positive breast cancer treatment: the promise and challenges of trastuzumab deruxtecan over trastuzumab emtansine—DESTINY-Breast03 trial
Editorial Commentary
Sex-specific approach to only optimize acetylsalicylic acid dosing for secondary prevention in cardiovascular disease is definitely questionable—insights from the ADAPTABLE trial and beyond
Editorial Commentary
Dual attack on multiple myeloma: targeting BCMA and CD19
Editorial Commentary
Assessing the UNICANCER-PRODIGE 23 trial through the lens of nonoperative management
Editorial Commentary
Lung cancer detection by electronic nose: ready for prime time?
Editorial Commentary
Botensilimab plus balstilimab in microsatellite stable metastatic colorectal cancer: light and gloom
Editorial Commentary
Eradication of Helicobacter pylori and its impact on the incidence of gastric cancer
Editorial Commentary
The central nervous system protective activity of selpercatinib from LIBRETTO-431
Editorial Commentary
Cabozantinib: a promising advancement in the treatment of advanced neuroendocrine tumors
Editorial Commentary
Abiraterone + olaparib in metastatic castration-resistant prostate cancer: tolerable, not toxic
Editorial Commentary
The CLL2-BAAG trial provides further evidence supporting a minimal residual disease driven approach and triple therapy in relapsed chronic lymphocytic leukaemia
Editorial Commentary
Is there a role for triple chemotherapy in advanced biliary tract cancer?
Editorial Commentary
The UNION trial: open the door to immune checkpoint inhibitors for proficient mismatch repair/microsatellite stability rectal cancer?
Editorial Commentary
Balancing treatment efficacy and complications in early-onset locally advanced rectal cancer
Editorial Commentary
Nutrition following esophagectomy, what’s best?
Editorial Commentary
Early implementation of exercise after breast cancer surgery: insights and opportunity
Editorial Commentary
The new kid on the block: will asciminib change frontline therapy of chronic myeloid leukemia patients?
Editorial Commentary
Transforming post-surgical lung cancer recovery: app-based approach to telerehabilitation
Editorial Commentary
COSMIC-312: lessons learned from another combination immune checkpoint and multi-kinase inhibitor trial
Editorial Commentary
Novel extended quadruplet induction regimens—challenging the need for upfront high-dose therapy in newly diagnosed all-risk multiple myeloma patients
Editorial Commentary